|
| 36599136 | Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. | Am J Gastroenterol | 2023 |
| 37938000 | Hepatitis C virus infects and perturbs liver stem cells. | mBio | 2023 |
| 37731497 | Cyclone: an accessible pipeline to analyze, evaluate, and optimize multiparametric cytometry data. | Front Immunol | 2023 |
| 34743343 | Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort. | Hepatology | 2022 |
| 35232252 | Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system. | Open Biol | 2022 |
| 34355475 | Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study. | J Viral Hepat | 2021 |
| 33893706 | Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America. | J Viral Hepat | 2021 |
| 30549279 | Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection. | Hepatology | 2019 |
| 31658127 | Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia. | Am J Gastroenterol | 2019 |
| 30709419 | Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers. | Epigenetics Chromatin | 2019 |
| 30974509 | Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. | J Viral Hepat | 2019 |
| 29563320 | An OX40/OX40L interaction directs successful immunity to hepatitis B virus. | Sci Transl Med | 2018 |
| 30010856 | Epigenetic changes of the thioredoxin system in the tx-j mouse model and in patients with Wilson disease. | Hum Mol Genet | 2018 |
| 26457468 | Liver capsule: Age-influenced hepatic immune priming determines HBV infection fate: Implications from mouse to man. | Hepatology | 2016 |
| 26138653 | Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir. | Dig Dis Sci | 2015 |
| 26189433 | Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. | Lancet Infect Dis | 2015 |
| 25136121 | Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients. | Proc Natl Acad Sci U S A | 2014 |
| 23925290 | Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. | J Clin Invest | 2013 |
| 21898189 | KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies. | Immunogenetics | 2012 |
| 21143342 | Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic. | J Viral Hepat | 2011 |
| 21393863 | IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. | J Clin Invest | 2011 |
| 20345567 | A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME). | Transfusion | 2010 |
| 19764883 | Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. | J Infect Dis | 2009 |
| 17181584 | Antibodies to a novel antigen in acute hepatitis C virus infections. | Vox Sang | 2007 |
| 17493654 | High levels of subgenomic HCV plasma RNA in immunosilent infections. | Virology | 2007 |
| 12601359 | Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. | Hepatology | 2003 |
| 11172332 | Acute hepatitis C. | Hepatology | 2001 |
| 11564803 | A novel, nonclassical MHC class I molecule specific to the common chimpanzee. | J Immunol | 2001 |
| 11095746 | MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. | Proc Natl Acad Sci U S A | 2000 |
| 10866107 | Common chimpanzees have greater diversity than humans at two of the three highly polymorphic MHC class I genes. | Immunogenetics | 2000 |
| 10894168 | Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. | Immunity | 2000 |
| 10972495 | Lessons in defense: hepatitis C, a case study. | Curr Opin Microbiol | 2000 |
| 9916684 | Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules. | J Immunol | 1999 |
| 10229187 | Analysis of a successful immune response against hepatitis C virus. | Immunity | 1999 |
| 9435339 | A major histocompatibility complex class I allele shared by two species of chimpanzee. | Immunogenetics | 1998 |
| 9174148 | HLA class I genotyping by cDNA sequence of a Vietnamese family expressing a weak B46 antigen. | Tissue Antigens | 1997 |
| 8666933 | Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees. | J Exp Med | 1996 |
| 8627179 | The presentation of a hepatitis C viral peptide by distinct major histocompatibility complex class I allotypes from two chimpanzee species. | J Exp Med | 1996 |